Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title	Phase	Last Update
Phase 2a Study to Assess Safety and Efficacy of Two Lu-177-TLX250 Dosing Regimens in Advanced Relapsed or Recurrent ccRCC (LUTEON ATLAS) Phase 2 Last update: October 13	Phase 2	October 13
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer Phase 1 Last update: October 13	Phase 1	October 13
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy Phase 2 Last update: October 13	Phase 2	October 13
Radioimmunotherapy with Lu-177 Labeled 6A10 Fab-fragments in Patients with Glioblastoma After Standard Treatment (RIT in GBM) Phase 1 Last update: October 13	Phase 1	October 13
A Phase Ib/II Open-label Study of AMO959 with Lutetium (Lu-177) Vipivotide Tetraxetan (AAA617) in Combination with ARPI in Adult Participants with PSMA-positive mCRPC Phase 1 Last update: October 9	Phase 1	October 9
Phase 1/2 Clinical Study of Lutetium Lu-177 JH020002 Injection in Patients with Advanced Prostate Cancer Phase 1 Last update: October 9	Phase 1	October 9
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (Lu-177) Vipivotide Tetraxetan in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) Phase 2 Last update: October 9	Phase 2	October 9
Phase I Study of [Lu-177]Lu-DFC413 in Patients with Solid Tumors Phase 1 Last update: October 9	Phase 1	October 9
An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients with Recurrent GBM (ODYSSEY) N/A Last update: October 9	N/A	October 9
A Study of Lu-177-DTPA-Omburtamab in Children and Adolescents with Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) Phase 1 Last update: October 8	Phase 1	October 8